Shopping Cart 0
Cart Subtotal
USD 0

Qu Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Qu Biologics Inc (Qu Biologics) is a developer of immunotherapies designed to restore normal immune function. The company develops site specific immunomodulators that restore the body's innate immune system to treat immune-related diseases and cancer. Its site specific immunotherapy technology restores normal immune function in the targeted tissue to reverse chronic inflammation in diseases including cancer, inflammatory bowel disease and other immune-related conditions. Qu Biologics' products are used in the treatment of inflammatory bowel disease, lung cancer, ovarian cancer, bone cancer, prostate cancer, ulcerative colitis, rheumatoid arthritis, and ulcerative colitis, among others. The company also offers preclinical research, retrospective studies, compassionate use program, and clinical trials program. It collaborates with other pharmaceutical companies and academic institutions. Qu Biologics is headquartered in Vancouver, British Columbia, Canada.

Qu Biologics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Qu Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Qu Biologics Raises USD4.6 Million in Venture Financing 10

Qu Biologics Raises USD1.1 Million in Venture Financing 11

Qu Biologics Raises USD1.7 Million in Venture Financing 12

Partnerships 13

Qu Biologics Enters into Research Agreement with University of British Columbia 13

Qu Biologics Enters into Research Agreement with University of Rochester 14

Equity Offering 15

Qu Biologics Raises USD3 Million in Equity Financing 15

Qu Biologics Raises USD2.5 Million in Private Placement 16

Qu Biologics Inc-Key Competitors 17

Qu Biologics Inc-Key Employees 18

Qu Biologics Inc-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Corporate Communications 20

May 15, 2018: Leading-edge Scientists in Innate Immunity Join Qu Biologics' Scientific Advisory Board 20

Nov 08, 2017: Qu Biologics recruits Ms. Jennifer Archibald, Chief Financial Officer, and Mr. Alun Rees, VP, Manufacturing, to Leadership Team 21

Government and Public Interest 22

Apr 04, 2017: Innovation Grant Awarded for Qu Biologics Project with University of Ottawa Scientist 22

Product News 23

Nov 28, 2017: Discovery of Innate Immune Mechanisms of a Novel Microbial-based Approach for the Treatment of Lung Cancer 23

05/23/2017: Qu Biologics Publishes Proof-of-Principle Data for Promising New Treatment for Chronic Obstructive Pulmonary Disease 24

05/03/2017: Qu Biologics invited to present Research Data at International Scientific Meetings 25

04/19/2017: High Response and Remission Rates in Anti-TNFa Naive Patients Treated with Qu Biologics' Novel Immune Therapy for Crohn's Disease 26

03/22/2017: Qu Biologics Discovers That Immune Biomarkers May Predict Response to Novel Immune Therapy for Crohns Disease 27

Clinical Trials 28

Mar 03, 2017: Qu Biologics Discovers Correlation Between Patient Genetics and Response to Immunotherapy in Inflammatory Bowel Disease 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Qu Biologics Inc, Pharmaceuticals & Healthcare, Key Facts 2

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Qu Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Qu Biologics Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Qu Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Qu Biologics Raises USD4.6 Million in Venture Financing 10

Qu Biologics Raises USD1.1 Million in Venture Financing 11

Qu Biologics Raises USD1.7 Million in Venture Financing 12

Qu Biologics Enters into Research Agreement with University of British Columbia 13

Qu Biologics Enters into Research Agreement with University of Rochester 14

Qu Biologics Raises USD3 Million in Equity Financing 15

Qu Biologics Raises USD2.5 Million in Private Placement 16

Qu Biologics Inc, Key Competitors 17

Qu Biologics Inc, Key Employees 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Qu Biologics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.